BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 7865538)

  • 1. Folate-mediated tumor cell targeting of liposome-entrapped doxorubicin in vitro.
    Lee RJ; Low PS
    Biochim Biophys Acta; 1995 Feb; 1233(2):134-44. PubMed ID: 7865538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of doxorubicin resistance in multidrug-resistance cells by targeted liposomes combined with hyperthermia.
    Gaber MH
    J Biochem Mol Biol Biophys; 2002 Oct; 6(5):309-14. PubMed ID: 12385965
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
    Xiang G; Wu J; Lu Y; Liu Z; Lee RJ
    Int J Pharm; 2008 May; 356(1-2):29-36. PubMed ID: 18258394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular uptake and intracavitary targeting of folate-conjugated liposomes in a mouse lymphoma model with up-regulated folate receptors.
    Shmeeda H; Mak L; Tzemach D; Astrahan P; Tarshish M; Gabizon A
    Mol Cancer Ther; 2006 Apr; 5(4):818-24. PubMed ID: 16648551
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pteroyl-gamma-glutamate-cysteine synthesis and its application in folate receptor-mediated cancer cell targeting using folate-tethered liposomes.
    Zhang Y; Guo L; Roeske RW; Antony AC; Jayaram HN
    Anal Biochem; 2004 Sep; 332(1):168-77. PubMed ID: 15301962
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Preparation and properties of folate receptor-targeted cationic liposomes].
    Yan Y; Qi XR
    Yao Xue Xue Bao; 2008 Nov; 43(11):1134-9. PubMed ID: 19239034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model.
    Pan XQ; Wang H; Lee RJ
    Pharm Res; 2003 Mar; 20(3):417-22. PubMed ID: 12669962
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
    J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
    Goren D; Horowitz AT; Tzemach D; Tarshish M; Zalipsky S; Gabizon A
    Clin Cancer Res; 2000 May; 6(5):1949-57. PubMed ID: 10815920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled targeting of liposomal doxorubicin via the folate receptor in vitro.
    Saul JM; Annapragada A; Natarajan JV; Bellamkonda RV
    J Control Release; 2003 Sep; 92(1-2):49-67. PubMed ID: 14499185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration.
    Riviere K; Huang Z; Jerger K; Macaraeg N; Szoka FC
    J Drug Target; 2011 Jan; 19(1):14-24. PubMed ID: 20353291
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo.
    Leamon CP; Cooper SR; Hardee GE
    Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strategy for the treatment of acute myelogenous leukemia based on folate receptor beta-targeted liposomal doxorubicin combined with receptor induction using all-trans retinoic acid.
    Pan XQ; Zheng X; Shi G; Wang H; Ratnam M; Lee RJ
    Blood; 2002 Jul; 100(2):594-602. PubMed ID: 12091353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design of folate-linked liposomal doxorubicin to its antitumor effect in mice.
    Yamada A; Taniguchi Y; Kawano K; Honda T; Hattori Y; Maitani Y
    Clin Cancer Res; 2008 Dec; 14(24):8161-8. PubMed ID: 19088031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional coating of liposomes using a folate- polymer conjugate to target folate receptors.
    Watanabe K; Kaneko M; Maitani Y
    Int J Nanomedicine; 2012; 7():3679-88. PubMed ID: 22888227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor activity of a folate receptor-targeted immunoglobulin G-doxorubicin conjugate.
    Yang T; Xu L; Li B; Li W; Ma X; Fan L; Lee RJ; Xu C; Xiang G
    Int J Nanomedicine; 2017; 12():2505-2515. PubMed ID: 28408821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 7-acetoxycoumarin dimer-incorporated and folate-decorated liposomes: photoresponsive release and in vitro targeting and efficacy.
    Seo HJ; Kim JC
    Bioconjug Chem; 2014 Mar; 25(3):533-42. PubMed ID: 24533729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting folate receptor with folate linked to extremities of poly(ethylene glycol)-grafted liposomes: in vitro studies.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Mandelbaum-Shavit F; Qazen MM; Zalipsky S
    Bioconjug Chem; 1999; 10(2):289-98. PubMed ID: 10077479
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeted temperature sensitive magnetic liposomes for thermo-chemotherapy.
    Pradhan P; Giri J; Rieken F; Koch C; Mykhaylyk O; Döblinger M; Banerjee R; Bahadur D; Plank C
    J Control Release; 2010 Feb; 142(1):108-21. PubMed ID: 19819275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isomeric folate-conjugated polymeric micelles bind to folate receptors and display anticancer effects.
    Dong Q; Xie ZX; Xie C; Lu WY; Zhang Q; Li X; Liu M
    Asian Pac J Cancer Prev; 2014; 15(17):7363-9. PubMed ID: 25227843
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.